
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (36): 4587-4594.DOI: 10.12114/j.issn.1007-9572.2023.0339
Special Issue: 肿瘤最新文章合辑; 消化系统疾病最新文章合辑
• Article • Previous Articles Next Articles
Received:2023-04-09
Revised:2023-07-12
Published:2023-12-20
Online:2023-07-21
Contact:
ZHOU Shangcheng
通讯作者:
周尚成
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0339
Figure 2 Changes in standardized mortality rate,DALYs rate,YLDs rate,and YLDs rate for esophageal cancer attributable to tobacco in China from 1990 to 2019
| 分类 | 时间(年) | APC(%) | 95%CI(%) | P值 | AAPC(%) | 95%CI(%) | P值 |
|---|---|---|---|---|---|---|---|
| 总人群 | 1990—1998 | -0.1 | (-0.4,0.1) | 0.027 | -1.4 | (-1.6,-1.2) | <0.001 |
| 总人群 | 1998—2004 | 1.8 | (1.3,2.3) | <0.001 | |||
| 总人群 | 2004—2014 | -4.4 | (-4.6,-4.3) | <0.001 | |||
| 总人群 | 2014—2017 | -2.2 | (-3.7,-0.7) | 0.007 | |||
| 总人群 | 2017—2019 | 0.5 | (1.3,2.3) | 0.055 | |||
| 女性 | 1990—1993 | 3.7 | (2.6,4.8) | <0.001 | -3.3 | (-3.6,-2.9) | <0.001 |
| 女性 | 1993—1998 | -0.2 | (-0.9,0.5) | 0.052 | |||
| 女性 | 1998—2001 | 1.4 | (-0.8,3.8) | 0.019 | |||
| 女性 | 2001—2004 | -1.1 | (-3.4,1.3) | 0.034 | |||
| 女性 | 2004—2015 | -8.3 | (-8.5,-8.2) | <0.001 | |||
| 女性 | 2015—2019 | -2.7 | (-3.3,-2.1) | <0.001 | |||
| 男性 | 1990—1997 | -0.6 | (-0.9,-0.3) | <0.001 | -1.3 | (-1.4,-1.1) | <0.001 |
| 男性 | 1997—2004 | 1.7 | (1.3,2.1) | <0.001 | |||
| 男性 | 2004—2015 | -3.8 | (-3.9,-3.6) | <0.001 | |||
| 男性 | 2015—2019 | -0.6 | (-1.2,-0.1) | 0.026 |
Table 1 Trends in esophageal cancer mortality attributable to tobacco in China from 1990 to 2019
| 分类 | 时间(年) | APC(%) | 95%CI(%) | P值 | AAPC(%) | 95%CI(%) | P值 |
|---|---|---|---|---|---|---|---|
| 总人群 | 1990—1998 | -0.1 | (-0.4,0.1) | 0.027 | -1.4 | (-1.6,-1.2) | <0.001 |
| 总人群 | 1998—2004 | 1.8 | (1.3,2.3) | <0.001 | |||
| 总人群 | 2004—2014 | -4.4 | (-4.6,-4.3) | <0.001 | |||
| 总人群 | 2014—2017 | -2.2 | (-3.7,-0.7) | 0.007 | |||
| 总人群 | 2017—2019 | 0.5 | (1.3,2.3) | 0.055 | |||
| 女性 | 1990—1993 | 3.7 | (2.6,4.8) | <0.001 | -3.3 | (-3.6,-2.9) | <0.001 |
| 女性 | 1993—1998 | -0.2 | (-0.9,0.5) | 0.052 | |||
| 女性 | 1998—2001 | 1.4 | (-0.8,3.8) | 0.019 | |||
| 女性 | 2001—2004 | -1.1 | (-3.4,1.3) | 0.034 | |||
| 女性 | 2004—2015 | -8.3 | (-8.5,-8.2) | <0.001 | |||
| 女性 | 2015—2019 | -2.7 | (-3.3,-2.1) | <0.001 | |||
| 男性 | 1990—1997 | -0.6 | (-0.9,-0.3) | <0.001 | -1.3 | (-1.4,-1.1) | <0.001 |
| 男性 | 1997—2004 | 1.7 | (1.3,2.1) | <0.001 | |||
| 男性 | 2004—2015 | -3.8 | (-3.9,-3.6) | <0.001 | |||
| 男性 | 2015—2019 | -0.6 | (-1.2,-0.1) | 0.026 |
| 年龄(岁) | AAPC(%) | 95%CI(%) | P值 |
|---|---|---|---|
| 30~34 | -1.7 | (-2.6,-0.8) | <0.001 |
| >34~39 | -2.2 | (-2.6,-1.8) | <0.001 |
| >39~44 | -3.0 | (-3.3,-2.8) | <0.001 |
| >44~49 | -2.7 | (-3.2,-2.2) | <0.001 |
| >49~54 | -2.4 | (-2.7,-2.1) | <0.001 |
| >54~59 | -2.3 | (-2.7,-1.9) | <0.001 |
| >59~64 | -1.8 | (-2,-1.6) | <0.001 |
| >64~69 | -1.8 | (-2.1,-1.4) | <0.001 |
| >69~74 | -1.3 | (-1.6,-1.1) | <0.001 |
| >74~79 | -1.0 | (-1.4,-0.6) | <0.001 |
| >79~84 | -0.5 | (-0.8,-0.1) | 0.007 |
| >84~89 | 0.2 | (0,0.5) | 0.042 |
| >89~94 | -0.6 | (-0.9,-0.2) | 0.001 |
| ≥95 | -1.7 | (-2,-1.3) | <0.001 |
Table 2 Trends in age-specific mortality rates for esophageal cancer attributable to tobacco in China from 1990 to 2019
| 年龄(岁) | AAPC(%) | 95%CI(%) | P值 |
|---|---|---|---|
| 30~34 | -1.7 | (-2.6,-0.8) | <0.001 |
| >34~39 | -2.2 | (-2.6,-1.8) | <0.001 |
| >39~44 | -3.0 | (-3.3,-2.8) | <0.001 |
| >44~49 | -2.7 | (-3.2,-2.2) | <0.001 |
| >49~54 | -2.4 | (-2.7,-2.1) | <0.001 |
| >54~59 | -2.3 | (-2.7,-1.9) | <0.001 |
| >59~64 | -1.8 | (-2,-1.6) | <0.001 |
| >64~69 | -1.8 | (-2.1,-1.4) | <0.001 |
| >69~74 | -1.3 | (-1.6,-1.1) | <0.001 |
| >74~79 | -1.0 | (-1.4,-0.6) | <0.001 |
| >79~84 | -0.5 | (-0.8,-0.1) | 0.007 |
| >84~89 | 0.2 | (0,0.5) | 0.042 |
| >89~94 | -0.6 | (-0.9,-0.2) | 0.001 |
| ≥95 | -1.7 | (-2,-1.3) | <0.001 |
| [1] |
|
| [2] |
|
| [3] |
Global Burden of Disease Cancer Collaboration,
|
| [4] |
GBD 2017 Oesophageal Cancer Collaborators. The global,regional,and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol,2020,5(6):582-597. DOI:10.1016/S2468-1253(20)30007-8.
|
| [5] |
GBD Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and teRRitories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1223-1249. DOI:10.1016/S0140-6736(20)30752-2.
|
| [6] |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222. DOI:10.1016/S0140-6736(20)30925-9.
|
| [7] |
|
| [8] |
曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用[J]. 中国卫生统计,2019,36(5):787-791.
|
| [9] |
曾四清,李艳,刘珺,等. 两组序列数据趋势变化特征对比分析的Joinpoint回归模型方法及应用[J]. 中国卫生统计,2021,38(2):307-311. DOI:10.3969/j.issn.1002-3674.2021.02.039.
|
| [10] |
李辉章,杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J]. 中华预防医学杂志,2020,54(8):908-912. DOI:10.3760/cma.j.cn112150-20200616-00889.
|
| [11] |
|
| [12] |
|
| [13] |
梁珊珊,周智华,李成程,等. 1990—2019年中国糖尿病疾病负担及发病预测分析[J]. 中国全科医学,2023,26(16):2013-2019. DOI:10.12114/j.issn.1007-9572.2023.0009.
|
| [14] |
许晴晴,严永富,陈浩,等. 中国四大慢性病死亡率可持续发展目标实现的预测研究[J]. 中华流行病学杂志,2022,43(6):878-884. DOI:10.3760/cma.j.cn112338-20211028-00830.
|
| [15] |
陈飞,王悠清. 1990—2019年中国食管癌疾病负担及其变化趋势分析[J]. 中国肿瘤,2021,30(6):401-407. DOI:10.11735/j.issn.1004-0242.2021.06.A001.
|
| [16] | |
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
健康中国行动(2019—2030年)[EB/OL].(2019-07-15)[2023-03-02].
|
| [1] | YUAN Yujuan, TAO Jing, WANG Ying, PENG Hui, YANG Yining. Elevated Neutrophil Percentage to Albumin Ratio is Associated with In-hospital Outcomes in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(18): 2489-2497. |
| [2] | LI Jiali, LIU Fan, KE Lixin, LI Huijuan, WANG Haibo, ZHAO Xiaoxiao, ZHAO Xinke, LU Cuncun. Disease Burden of Obesity among Individuals Aged 60 and above Globally and in China from 1990 to 2021: Trend Analysis and Model-based Projection [J]. Chinese General Practice, 2026, 29(15): 2067-2076. |
| [3] | ZHEN Rui, GU Xufang, GAO Shengwei, ZHANG Bowen, REN Zhenjuan, YANG Ruixuan. Burden of Cardiovascular Diseases Attributable to Metabolic Risk Factors in China 1990—2021 and Projected Trends from 2022 to 2035 [J]. Chinese General Practice, 2026, 29(15): 2077-2083. |
| [4] | QIU Yanli, GAO Yongyin, BIAN Xueyan, WANG Xue, LI Yue. The Predictive Value of Estimated Pulse Wave Velocity for All-cause and Cardiovascular-related Mortality in Cancer Patients [J]. Chinese General Practice, 2026, 29(14): 1890-1897. |
| [5] | CHEN Xueqin, WANG Shihong, LAI Fengxia, ZHANG Jingjing, CHEN Hao, KONG Danli, DING Yuanlin. Study on Trend Analysis and Forecast of Incidence, Disease and Mortality of Chronic Obstructive Pulmonary Disease in China, 1990-2021 [J]. Chinese General Practice, 2026, 29(02): 264-272. |
| [6] | YANG Qinghui, HU Yingxue, NI Pingwei, LIU Xiao. Analysis of the Incidence and Mortality Trends of Lung Cancer in China from 1990 to 2021 and Prediction for 2035 [J]. Chinese General Practice, 2026, 29(02): 256-263. |
| [7] | MI Lingyu, CHEN Lianxin, GAO Hengbo, WANG Bincheng. Predictive Value of Triglyceride-glucose Index for Prognosis in Patients with Pulmonary Embolism [J]. Chinese General Practice, 2025, 28(35): 4421-4429. |
| [8] | ZHANG Hui, LUO Miaomiao, YU Xiaohang, LIN Xin, YE Lina, TANG Xuan, LI Jiaxue, XIE Xinyu, LAI Li, FENG Yan, LIU Yonghui, CHEN Weigang. The Application Value of a Novel Cell Collector for the Esophagus in Screening for Esophageal Lesions [J]. Chinese General Practice, 2025, 28(35): 4487-4493. |
| [9] | ZHANG Yongqing, LI Na, GAO Yili, QIN Jiawen, YU Haiping, SHI Hui. Analysis on the Trend of Disease Burden of Hearing Loss in Middle-aged and Elderly People in China from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(33): 4227-4233. |
| [10] | LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu. Interpretation of Report on Cardiovascular Health and Diseases in China 2024 [J]. Chinese General Practice, 2025, 28(32): 3989-4008. |
| [11] | ZHANG Ji, ZHOU Jie, LI Ling, WU Yanli, JI Wei, LIU Tao. Associations of Fasting Blood Glucose with All-cause Mortality and Specific-cause Mortality in a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(31): 3924-3931. |
| [12] | SHANG Zhonghua, JIANG Zhiyue, HUANG Zhaohui, YANG Xing, LIU Haiyan, ZHANG Li. Trends in Cervical Cancer Burden in China from 1990 to 2021 and Prediction for 2022 to 2035 [J]. Chinese General Practice, 2025, 28(26): 3314-3320. |
| [13] | LUO Xinyu, LIU Jin, CHEN Hailong. Trend Analysis of the Changing Disease Burden of Pancreatitis in China and Worldwide from 1990 to 2021 and Prediction for 2022 to 2031 [J]. Chinese General Practice, 2025, 28(26): 3321-3327. |
| [14] | SHI Xiaotian, WANG Shan, YANG Huayu, YANG Yifan, LI Xu, MA Qing. Association between Body Mass Index and Mortality among Older Chinese: a Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2791-2797. |
| [15] | LI Qiujing, SHANG Na, GAO Qian, YANG Li, GUO Shubin. Predictive Value of Abdominal CT Based-skeletal Muscle Mass Combined with Critical Illness Score for Prognosis in Older Patients with Intra-abdominal Sepsis [J]. Chinese General Practice, 2025, 28(12): 1459-1464. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||